BRIEF published on 11/20/2025 at 16:05, 14 days 12 hours ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Form 8.3 Zürcher Kantonalbank Takeover Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 11/20/2025 at 16:00, 14 days 12 hours ago Form 8.3 - Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose 0.04% interest in Avadel Pharmaceuticals plc as of 19th November 2025. No other party involved. No dealings reported Disclosure Dealings Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 11/19/2025 at 16:20, 15 days 12 hours ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals plc Disclosure Irish Takeover Panel Zürcher Kantonalbank Securities Interests Avadel Pharmaceuticals
PRESS RELEASE published on 11/19/2025 at 16:15, 15 days 12 hours ago Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.17% interest in Avadel Pharmaceuticals plc as of 18th November 2025 under Rule 8.3 of the Irish Takeover Panel Act, 1997 Irish Takeover Panel Rule 8.3 Interest Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 11/18/2025 at 17:57, 16 days 10 hours ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 11/18/2025 at 17:52, 16 days 10 hours ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses a 1.17% stake in Avadel Pharmaceuticals plc as of 17th November 2025 under Rule 8.3 of Irish Takeover Panel Act Stake Disclosure Zürcher Kantonalbank 1.17% Irish Takeover Panel Act Avadel Pharmaceuticals Plc
BRIEF published on 11/12/2024 at 15:05, 1 year ago Disclosure of Zürcher Kantonalbank's Position in Tritax EuroBox PLC Form 8.3 Takeover Code Securities Disclosure Zürcher Kantonalbank Tritax EuroBox
PRESS RELEASE published on 11/12/2024 at 15:00, 1 year ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses a 0.776% ownership of Registered Shares in Tritax EuroBox PLC. Position disclosed on 11th Nov 2024 Position Disclosure Ownership Disclosure Zürcher Kantonalbank Registered Shares Tritax EuroBox Plc
BRIEF published on 11/08/2024 at 14:05, 1 year ago Zürcher Kantonalbank Discloses Position in Tritax EuroBox Takeover Code Securities Disclosure Zürcher Kantonalbank Registered Shares Tritax EuroBox
PRESS RELEASE published on 11/08/2024 at 14:00, 1 year ago Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC Zürcher Kantonalbank discloses a 1.024% stake in Tritax EuroBox PLC through registered shares. The bank sold 79,000 shares at EUR 0.841 per unit on November 7, 2024 Stake Disclosure Share Sale Zürcher Kantonalbank Registered Shares Tritax EuroBox Plc
Published on 12/05/2025 at 02:35, 1 hour 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 3 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 5 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 5 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 4 hours 43 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 8 hours 19 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 9 hours 23 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 10 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 10 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 10 hours 50 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 21 hours 33 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 10 hours ago Declaration of voting rights at the end of November 2025
